|
Secondary prevention
Citations 511-520 of 568 total displayed.
|
Past content
(since Feb 1999):
|
- Special Reports
Trends and Disparities in Coronary Heart Disease, Stroke, and Other Cardiovascular Diseases in the United States : Findings of the National Conference on Cardiovascular Disease Prevention
- Richard Cooper, Jeffrey Cutler, Patrice Desvigne-Nickens, Stephen P. Fortmann, Lawrence Friedman, Richard Havlik, Gary Hogelin, John Marler, Paul McGovern, Gregory Morosco, Lori Mosca, Thomas Pearson, Jeremiah Stamler, Daniel Stryer, and Thomas Thom
Circulation 2000;102:3137-3147
[Abstract]
[Full text]
- Clinical Investigations and Reports
Effects of a Residential Exercise Training on Baroreflex Sensitivity and Heart Rate Variability in Patients With Coronary Artery Disease : A Randomized, Controlled Study
- Ferdinando Iellamo, Jacopo M. Legramante, Michele Massaro, Gianfranco Raimondi, and Alberto Galante
Circulation 2000;102:2588-2592
[Abstract]
[Full text]
- Clinical Investigations and Reports
Improved Vascular Endothelial Function After Oral B Vitamins : An Effect Mediated Through Reduced Concentrations of Free Plasma Homocysteine
- John C. Chambers, Per M. Ueland, Omar A. Obeid, Jane Wrigley, Helga Refsum, and Jaspal S. Kooner
Circulation 2000;102:2479-2483
[Abstract]
[Full text]
- Surgery for Coronary Artery Disease
HDL Cholesterol Level Predicts Survival in Men After Coronary Artery Bypass Graft Surgery : 20-Year Experience From The Cleveland Clinic Foundation
- JoAnne Micale Foody, Francis D. Ferdinand, Gregory L. Pearce, Bruce W. Lytle, Delos M. Cosgrove, and Dennis L. Sprecher
Circulation 2000;102:III-90-94III-
[Abstract]
[Full text]
- Clinical Investigations and Reports
Efficacy and Safety of Oral Dofetilide in Converting to and Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation or Atrial Flutter : The Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study
- Steven Singh, Robert G. Zoble, Laurence Yellen, Michael A. Brodsky, Gregory K. Feld, Martin Berk, and Clare B. Billing, Jr
Circulation 2000;102:2385-2390
[Abstract]
[Full text]
- AHA Scientific Statements
Team Management of Patients With Heart Failure : A Statement for Healthcare Professionals From the Cardiovascular Nursing Council of the American Heart Association
- Kathleen L. Grady, Kathleen Dracup, Gemma Kennedy, Debra K. Moser, Mariann Piano, Lynne Warner Stevenson, and James B. Young
Circulation 2000;102:2443-2456
[Full text]
- Clinical Investigations and Reports
Change in Level of Physical Activity and Risk of All-Cause Mortality or Reinfarction : The Corpus Christi Heart Project
- Lyn Steffen-Batey, Milton Z. Nichaman, David C. Goff, Jr, Ralph F. Frankowski, Craig L. Hanis, David J. Ramsey, and Darwin R. Labarthe
Circulation 2000;102:2204-2209
[Abstract]
[Full text]
- Clinical Investigations and Reports
Peripheral Arterial Disease in Randomized Trial of Estrogen With Progestin in Women With Coronary Heart Disease : The Heart and Estrogen/Progestin Replacement Study
- Judith Hsia, Joel A. Simon, Feng Lin, William B. Applegate, Molly T. Vogt, Donald Hunninghake, and Margaret Carr
Circulation 2000;102:2228-2232
[Abstract]
[Full text]
- Clinical Investigations and Reports
VLDL, Apolipoproteins B, CIII, and E, and Risk of Recurrent Coronary Events in the Cholesterol and Recurrent Events (CARE) Trial
- Frank M. Sacks, Petar Alaupovic, Lemuel A. Moye, Thomas G. Cole, Bruce Sussex, Meir J. Stampfer, Marc A. Pfeffer, and Eugene Braunwald
Circulation 2000;102:1886-1892
[Abstract]
[Full text]
- Clinical Investigations and Reports
Effect of Pravastatin on Coronary Disease Events in Subgroups Defined by Coronary Risk Factors : The Prospective Pravastatin Pooling Project
- Frank M. Sacks, Andrew M. Tonkin, James Shepherd, Eugene Braunwald, Stuart Cobbe, C. Morton Hawkins, Anthony Keech, Christopher Packard, John Simes, Robert Byington, and Curt D. Furberg
Circulation 2000;102:1893-1900
[Abstract]
[Full text]
|
|